tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals (DE:VX1)
XETRA:VX1
Germany Market
Advertisement

Vertex Pharmaceuticals (VX1) Financial Statements

Compare
23 Followers

Vertex Pharmaceuticals Financial Overview

Vertex Pharmaceuticals's market cap is currently $84.51B. The company's EPS TTM is €3.8556518915999995; its P/E ratio is 25.69; Vertex Pharmaceuticals is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is €3.92. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History

Vertex Pharmaceuticals Debt to Assets

Vertex Pharmaceuticals Cash Flow

Vertex Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis